Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -0.97 |
| peg ratio | -0.02 |
| price to book ratio | -0.66 |
| price to sales ratio | 0.61 |
| enterprise value multiple | 0.17 |
| price fair value | -0.66 |
profitability ratios | |
|---|---|
| gross profit margin | 95.86% |
| operating profit margin | -89.89% |
| pretax profit margin | -61.53% |
| net profit margin | -61.72% |
| return on assets | -42.02% |
| return on equity | 66.89% |
| return on capital employed | -83.75% |
liquidity ratio | |
|---|---|
| current ratio | 3.62 |
| quick ratio | 3.56 |
| cash ratio | 1.47 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 210.54 |
| operating cycle | 305.75 |
| days of payables outstanding | 169.42 |
| cash conversion cycle | 136.33 |
| receivables turnover | 3.83 |
| payables turnover | 2.15 |
| inventory turnover | 1.73 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.91 |
| debt equity ratio | -1.47 |
| long term debt to capitalization | 3.24 |
| total debt to capitalization | 3.11 |
| interest coverage | -4.83 |
| cash flow to debt ratio | -0.67 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.08 |
| cash per share | 1.26 |
| operating cash flow per share | -1.08 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.67 |
| short term coverage ratios | -36.77 |
| capital expenditure coverage ratio | -668.40 |
Frequently Asked Questions
Karyopharm Therapeutics Inc. (KPTI) published its most recent earnings results on 06-08-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Karyopharm Therapeutics Inc. (NASDAQ:KPTI)'s trailing twelve months ROE is 66.89%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Karyopharm Therapeutics Inc. (KPTI) currently has a ROA of -42.02%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
KPTI reported a profit margin of -61.72% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.62 in the most recent quarter. The quick ratio stood at 3.56, with a Debt/Eq ratio of -1.47.